Senolytic CAR T cells as novel therapeutic concept for solid tumors and senescence-associated diseases.

Project Information

CARsen

Grant agreement ID: 949667

DOI

10.3030/949667

EC signature date 18 January 2021

Start date 1 January 2022

End date 31 December 2027

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 818 637,50

EU contribution

€ 1 818 637,00

Coordinated by

EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction

Author(s): Corina Amor, Inés Fernández-Maestre, Saria Chowdhury, Yu-Jui Ho, Sandeep Nadella, Courtenay Graham, Sebastian E. Carrasco, Emmanuella Nnuji-John, Judith Feucht, Clemens Hinterleitner, Valentin J. A. Barthet, Jacob A. Boyer, Riccardo Mezzadra, Matthew G. Wereski, David A. Tuveson, Ross L. Levine, Lee W. Jones, Michel Sadelain, Scott W. Lowe
Published in: Nature Aging, Issue 4, 2024, Page(s) 336-349, ISSN 2662-8465
Publisher: Nature Portfolio
DOI: 10.1038/s43587-023-00560-5